175 related articles for article (PubMed ID: 37754486)
1. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing.
Wilkinson AN; Seely JM; Rushton M; Williams P; Cordeiro E; Allard-Coutu A; Look Hong NJ; Moideen N; Robinson J; Renaud J; Mainprize JG; Yaffe MJ
Curr Oncol; 2023 Aug; 30(9):7860-7873. PubMed ID: 37754486
[TBL] [Abstract][Full Text] [Related]
2. [Cost of breast cancer treatment by clinical stage in the Basque Country, Spain].
Arrospide A; Soto-Gordoa M; Acaiturri T; López-Vivanco G; Abecia LC; Mar J
Rev Esp Salud Publica; 2015; 89(1):93-7. PubMed ID: 25946589
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach.
Khan SA; Hernandez-Villafuerte K; Hernandez D; Schlander M
Front Public Health; 2022; 10():946544. PubMed ID: 36684975
[TBL] [Abstract][Full Text] [Related]
4. A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer.
Brezden-Masley C; Fathers KE; Coombes ME; Pourmirza B; Xue C; Jerzak KJ
Breast Cancer Res Treat; 2021 Jan; 185(2):507-515. PubMed ID: 33064230
[TBL] [Abstract][Full Text] [Related]
5. The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data.
Borges A; Pereira F; Redondo P; Antunes L; Vieira C; Antunes P; Bento MJ; Sousa S; Lopes JM; Rocha-Gonçalves F; de Sousa JA; Pereira DS; Borges M
Health Econ Rev; 2021 Sep; 11(1):33. PubMed ID: 34505956
[TBL] [Abstract][Full Text] [Related]
6. [Breast Cancer: Value-Based Healthcare, Costs and Financing].
Harfouche A; Silva S; Faria J; Araújo R; Gouveia A; Lacerda M; D'Orey L
Acta Med Port; 2017 Nov; 30(11):762-768. PubMed ID: 29279067
[TBL] [Abstract][Full Text] [Related]
7. Population-based home care services in breast cancer: utilization and costs.
Mittmann N; Isogai PK; Saskin R; Liu N; Porter JM; Cheung MC; Leighl NB; Hoch JS; Trudeau ME; Evans WK; Dainty KN; Earle CC
Curr Oncol; 2012 Dec; 19(6):e383-91. PubMed ID: 23300362
[TBL] [Abstract][Full Text] [Related]
8. Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort study.
Mittmann N; Liu N; Cheng SY; Seung SJ; Saxena FE; Look Hong NJ; Earle CC; Cheung MC; Leighl NB; Coburn NG; DeAngelis C; Evans WK
CMAJ Open; 2020; 8(1):E191-E198. PubMed ID: 32184283
[TBL] [Abstract][Full Text] [Related]
9. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
[TBL] [Abstract][Full Text] [Related]
10. Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review.
Palacios A; Rojas-Roque C; González L; Bardach A; Ciapponi A; Peckaitis C; Pichon-Riviere A; Augustovski F
Pharmacoeconomics; 2021 May; 39(5):485-502. PubMed ID: 33782865
[TBL] [Abstract][Full Text] [Related]
11. Costs of breast cancer treatment incurred by women in Vietnam.
Ngan TT; Ngoc NB; Van Minh H; Donnelly M; O'Neill C
BMC Public Health; 2022 Jan; 22(1):61. PubMed ID: 35012517
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
[TBL] [Abstract][Full Text] [Related]
13. Costs structure of the inpatient ischemic stroke treatment using an exact costing method.
Puumalainen A; Elonheimo O; Brommels M
Heliyon; 2020 Jun; 6(6):e04264. PubMed ID: 32613126
[TBL] [Abstract][Full Text] [Related]
14. Costs of breast cancer treatment prior to the introduction of immune-based therapy in Mexico.
Meneses-García A; Ramírez T; Ruiz-Godoy L; Chiquete E; Mohar A
Rev Med Inst Mex Seguro Soc; 2012; 50(1):19-24. PubMed ID: 22768813
[TBL] [Abstract][Full Text] [Related]
15. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
[TBL] [Abstract][Full Text] [Related]
16. Variability in hospital treatment costs: a time-driven activity-based costing approach for early-stage invasive breast cancer patients.
Roman E; Cardoen B; Decloedt J; Roodhooft F
BMJ Open; 2020 Jul; 10(7):e035389. PubMed ID: 32641325
[TBL] [Abstract][Full Text] [Related]
17. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
Moger TA; Bjørnelv GM; Aas E
Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
[TBL] [Abstract][Full Text] [Related]
18. [Direct medical costs in a cohort of patients with breast cancer].
de la Cruz-Aguirre K; Cortés-Sanabria L; Salas-González E; Canales-Muñoz JL; Aguayo-Alcaraz G; Ayala-Cortés RA; Palomares-Hernández CY
Rev Med Inst Mex Seguro Soc; 2022 Mar; 60(2):107-115. PubMed ID: 35704991
[TBL] [Abstract][Full Text] [Related]
19. Developing a costing framework for palliative care services.
Mosoiu D; Dumitrescu M; Connor SR
J Pain Symptom Manage; 2014 Oct; 48(4):719-29. PubMed ID: 24709365
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
